GV has led a $14.5m series A round for Blue Vision, which has emerged from stealth as it prepares to roll out its collaborative augmented reality platform.

Microsoft Ventures, which took part in the game-based learning platform's series A round, has returned for a round that valued it at $100m.

The Illumina-backed DNA and RNA sequencer provider raised the funding from investors including GIC, Hostplus and China Construction Bank.

The Lund University spinout, which is working on diagnostics technology for applications in oncology, will use the proceeds to pursue a recruitment drive.

The mobile banking platform has closed a round co-led by Tencent and Allianz X, boosting its total funding to $215m as it prepares to enter the UK and US.

The electric bicycle drive manufacturer has been backed by Unternehmertum Venture Capital Partners.

The spinout, which has developed a portable real-time DNA and RNA sequencer, has attracted $140m in funding from investors including GIC, China Construction Bank and Hostplus.

Julia Hawkins, formerly head of strategy and investments for Universal Music UK, has joined venture firm LocalGlobe as a partner.

Prexton Therapeutics, a Parkinson's disease-focused spinoff of Merck Group that had raised $41m in funding, has agreed to an acquisition that could reach more than $1.1bn in size.